Fennec Pharmaceuticals Inc. (T.FRX)

Last Closing Price: --

Days Sales in Receivables (Quarterly)

Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover

Fennec Pharmaceuticals Inc. (T.FRX) had Days Sales in Receivables of 139.69 for the most recently reported fiscal quarter, ending 2025-09-30.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
--
-0.88M
--
--
--
-0.26M
--
-0.88M
-0.88M
-0.88M
-0.88M
-0.88M
-0.88M
-0.26M
-0.24M
27.89M
27.89M
-0.03
-0.03
Balance Sheet Financials
--
--
--
67.86M
--
--
--
74.05M
-6.19M
-6.19M
-6.19M
28.06M
Cash Flow Statement Financials
-8.97M
--
2.51M
36.69M
30.23M
-6.46M
6.21M
--
--
Fundamental Metrics & Ratios
4.69
--
--
1.33
-4.03
94.70%
-1.52%
-1.52%
--
-5.12%
-5.12%
-8.97M
--
--
--
0.25
0.27
0.64
Days Sales in Receivables
139.69
14.20%
14.20%
-1.30%
-4.69%
-0.22
-0.32
-0.32